Fund Holdings — Vivo Capital, LLC

Total Portfolio Value:
$1.21B
Total Bought:
$90.07M
Total Sold:
$156.52M
Net Transaction:
-$66.44M
Notable People:
Edgar George Engleman, Frank Fang-Chien Kung, Shan (Nmn) Fu, Michael J. Chang, Gaurav Aggarwal
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Soleno Therapeutics Inc7,316,8516,291,851-1,025,000$298.53M$317.68M26.29%+$19.15M
Geron Corporation(GERN)27,225,29227,225,2920$115.44M$123.60M10.23%+$8.17M
Harmony Biosciences Holdings, Inc.(HRMY)2,606,2472,606,2470$78.63M$104.25M8.63%+$25.62M
Verona Pharma PLCADS3,549,7583,549,7580$51.33M$102.13M8.45%+$50.80M
Sinovac Biotech, Ltd.SHS(SVA)11,800,00011,800,0000$76.35M$76.35M6.32%$0
Terns Pharmaceuticals Inc6,182,9926,895,746+712,754$42.11M$57.51M4.76%+$15.40M
Instil Bio, Inc.(TIL)624,339624,3390$6.42M$42.03M3.48%+$35.61M
Dyne Therapeutics, Inc.(DYN)1,635,1361,114,960-520,176$57.70M$40.05M3.31%-$17.65M
Viridian Therapeutics, Inc.(VRDN)1,678,2071,678,2070$21.83M$38.18M3.16%+$16.35M
Avadel Pharmaceuticals PLCADR02,684,109+2,684,109$0$35.20M2.91%+$35.20M
Silence Therapeutics plcADS(SLN)1,105,4541,105,4540$21.00M$20.10M1.66%-$906.5K
Zenas BioPharma, Inc.(ZBIO)01,183,260+1,183,260$0$20.02M1.66%+$20.02M
Erasca, Inc.(ERAS)6,756,7566,756,7560$15.95M$18.45M1.53%+$2.50M
Olema Pharmaceuticals, Inc.(OLMA)1,873,7041,505,862-367,842$20.27M$17.98M1.49%-$2.29M
Astria Therapeutics Inc2,329,0271,552,685-776,342$21.19M$17.10M1.41%-$4.10M
Tourmaline Bio Inc.591,882591,8820$7.61M$15.22M1.26%+$7.61M
Rezolute, Inc.(RZLT)2,797,7042,797,7040$12.03M$13.57M1.12%+$1.54M
ORIC Pharmaceuticals, Inc.(ORIC)1,269,6761,277,818+8,142$8.98M$13.10M1.08%+$4.12M
Sera Prognostics, Inc.(SERA)1,650,4401,650,4400$9.77M$12.87M1.07%+$3.10M
Cogent Biosciences, Inc.(COGT)2,244,9411,122,471-1,122,470$18.92M$12.12M1.00%-$6.80M
Abeona Therapeutics Inc.(ABEO)1,842,7511,842,7510$7.81M$11.65M0.96%+$3.83M
COMPASS Pathways plcADS(CMPS)1,608,0001,608,0000$9.71M$10.13M0.84%+$418.1K
Celcuity Inc.(CELC)610,500610,5000$10.00M$9.10M0.75%-$897.4K
Delcath Systems, Inc.(DCTH)1,666,746997,005-669,741$13.95M$9.00M0.75%-$4.95M
Corvus Pharmaceuticals, Inc.(CRVS)01,497,268+1,497,268$0$7.91M0.65%+$7.91M
Regulus Therapeutics Inc5,000,0005,000,0000$8.93M$7.85M0.65%-$1.07M
ALX Oncology Holdings Inc.(ALXO)4,220,0484,034,522-185,526$25.45M$7.34M0.61%-$18.10M
Compass Therapeutics, Inc.(CMPX)3,556,0233,556,0230$3.56M$6.54M0.54%+$2.99M
IO Biotech Inc6,173,4396,173,4390$7.22M$6.48M0.54%-$740.8K
Adverum Biotechnologies, Inc.833,333833,3330$833.3K$5.85M0.48%+$5.02M
Trevi Therapeutics, Inc.(TRVI)01,612,903+1,612,903$0$5.39M0.45%+$5.39M
Verastem, Inc.(VSTM)1,538,4611,538,4610$4.58M$4.60M0.38%+$15.4K
Engene Holdings Inc.
COM
678,705678,7050$6.40M$4.48M0.37%-$1.92M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)166,794166,7940$7.55M$3.44M0.28%-$4.11M
Bolt Therapeutics Inc3,521,2913,521,2910$2.64M$2.28M0.19%-$359.2K
Allakos Inc2,988,0002,956,110-31,890$2.99M$1.93M0.16%-$1.06M
Unicycive Therapeutics3,470,1524,470,152+1,000,000$1.74M$1.82M0.15%+$84.5K
Aligos Therapeutics, Inc.(ALGS)0141,879+141,879$0$1.23M0.10%+$1.23M
Codexis, Inc.(CDXS)388,144388,1440$1.20M$1.20M0.10%-$7.8K
DBV Technologies SAADS1,354,4371,354,4370$1.08M$948.1K0.08%-$136.8K
Q32 Bio Inc.(QTTB)20,55920,5590$369.0K$917.3K0.08%+$548.3K
Tenax Therapeutics, Inc.(TENX)0208,333+208,333$0$720.8K0.06%+$720.8K
Precision BioSciences, Inc.(DTIL)4,6754,6750$45.5K$41.9K0.00%-$3.6K
Whitehawk Therapeutics, Inc.(WHWK)509,5720-509,572$744.0K$0—-$744.0K
Aligos Therapeutics Inc3,547,0300-3,547,030$1.24M$0—-$1.24M
Avadel Pharmaceuticals PLCADR3,972,0990-3,972,099$55.85M$0—-$55.85M
Tarsus Pharmaceuticals, Inc.(TARS)565,5500-565,550$15.37M$0—-$15.37M
Zai Lab LimitedADR(ZLAB)531,1980-531,198$9.21M$0—-$9.21M
Page 1 of 1
Vivo Capital, LLC — 13F Holdings — Q3 2024 | TickerTrail